|
SG11201908784TA
(en)
*
|
2017-03-27 |
2019-10-30 |
Hoffmann La Roche |
Improved antigen binding receptor formats
|
|
CN110526987A
(zh)
*
|
2018-05-25 |
2019-12-03 |
深圳宾德生物技术有限公司 |
靶向cd133的嵌合抗原受体、嵌合抗原受体t细胞及其制备方法和应用
|
|
CN109735500B
(zh)
*
|
2019-01-25 |
2023-05-16 |
苏州茂行生物科技有限公司 |
一种分泌型靶向cd133的car-t细胞及其制备方法和应用
|
|
JP7137696B2
(ja)
|
2019-05-14 |
2022-09-14 |
プロヴェンション・バイオ・インコーポレイテッド |
１型糖尿病を予防するための方法および組成物
|
|
WO2020243479A1
(en)
|
2019-05-31 |
2020-12-03 |
The Johns Hopkins University |
Bispecific binding agents
|
|
EP3976649A4
(en)
*
|
2019-05-31 |
2022-12-14 |
The Johns Hopkins University |
B-SPECIFIC IL-6Ra/IL-8R BINDING AGENTS TO BLOCK MIGRATION OF CANCER CELLS
|
|
CN113912696B
(zh)
*
|
2019-07-24 |
2023-05-30 |
暨南大学 |
靶向cd133的结合蛋白与其应用
|
|
KR20230092863A
(ko)
|
2020-06-11 |
2023-06-26 |
프로벤션 바이오, 인코포레이티드 |
제1형 당뇨병을 예방하기 위한 방법 및 조성물
|
|
CN111529690B
(zh)
*
|
2020-06-17 |
2023-03-31 |
中国科学院昆明动物研究所 |
人cd133蛋白1-108肽段的新用途
|
|
CN114057875B
(zh)
*
|
2020-07-31 |
2023-05-05 |
北京市神经外科研究所 |
抗cd133的单链抗体及其在制备治疗肿瘤的药物中的用途
|
|
CN116420076A
(zh)
*
|
2020-09-27 |
2023-07-11 |
基因泰克公司 |
高通量多参数免疫细胞接合物筛选测定
|
|
US11661459B2
(en)
|
2020-12-03 |
2023-05-30 |
Century Therapeutics, Inc. |
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
|
|
IL303269A
(en)
|
2020-12-03 |
2023-07-01 |
Century Therapeutics Inc |
Genetically engineered cells and uses thereof
|
|
TW202241935A
(zh)
|
2020-12-18 |
2022-11-01 |
美商世紀治療股份有限公司 |
具有可調適受體專一性之嵌合抗原受體系統
|
|
JP2024500189A
(ja)
|
2020-12-21 |
2024-01-04 |
アロジーン セラピューティクス，インコーポレイテッド |
プロテアーゼ活性化ｃｄ４５ゲートｃａｒ
|
|
MX2023008809A
(es)
|
2021-01-29 |
2023-08-04 |
Allogene Therapeutics Inc |
ATENUACIÓN O INACTIVACIÓN DE UNO O MÁS DE TAP2, NLRC5, ß2M, TRAC, RFX5, RFXAP Y RFXANK PARA MITIGAR EL RECONOCIMIENTO DE CÉLULAS T DE PRODUCTOS CELULARES ALOGÉNICOS.
|
|
MX2023013851A
(es)
|
2021-05-24 |
2023-12-08 |
Provention Bio Inc |
Metodos para el tratamiento de diabetes tipo 1.
|
|
IL308809A
(en)
*
|
2021-06-04 |
2024-01-01 |
Amgen Res Munich Gmbh |
T cell binding compounds and their uses
|
|
CN114316050B
(zh)
*
|
2021-12-24 |
2022-11-11 |
北京市神经外科研究所 |
Cd133抗体、嵌合抗原受体及其应用
|
|
CN114213537B
(zh)
*
|
2021-12-24 |
2022-06-14 |
北京市神经外科研究所 |
Cd133抗体、嵌合抗原受体及其应用
|
|
US20250082777A1
(en)
|
2022-01-10 |
2025-03-13 |
Sana Biotechnology, Inc. |
Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses
|
|
US20240042030A1
(en)
|
2022-07-29 |
2024-02-08 |
Allogene Therapeutics, Inc. |
Engineered cells with reduced gene expression to mitigate immune cell recognition
|
|
WO2024040195A1
(en)
|
2022-08-17 |
2024-02-22 |
Capstan Therapeutics, Inc. |
Conditioning for in vivo immune cell engineering
|
|
EP4602174A1
(en)
|
2022-10-13 |
2025-08-20 |
Sana Biotechnology, Inc. |
Viral particles targeting hematopoietic stem cells
|
|
WO2024119157A1
(en)
|
2022-12-02 |
2024-06-06 |
Sana Biotechnology, Inc. |
Lipid particles with cofusogens and methods of producing and using the same
|
|
WO2024220597A2
(en)
|
2023-04-18 |
2024-10-24 |
Sana Biotechnology, Inc. |
Digital droplet based assay for detecting replication competent lentiviral vector
|
|
AU2024274792A1
(en)
|
2023-05-23 |
2025-10-23 |
Sana Biotechnology, Inc. |
Tandem fusogens and related lipid particles
|
|
EP4719352A1
(en)
|
2023-05-31 |
2026-04-08 |
Capstan Therapeutics, Inc. |
Lipid nanoparticle formulations and compositions
|
|
WO2025056957A1
(en)
*
|
2023-09-15 |
2025-03-20 |
Jimenez Mendoza, Dimas |
Peptide based medicines for treating cancer
|
|
WO2025076113A1
(en)
|
2023-10-05 |
2025-04-10 |
Capstan Therapeutics, Inc. |
Ionizable cationic lipids with conserved spacing and lipid nanoparticles
|
|
US20250127728A1
(en)
|
2023-10-05 |
2025-04-24 |
Capstan Therapeutics, Inc. |
Constrained Ionizable Cationic Lipids and Lipid Nanoparticles
|
|
KR20260105764A
(ko)
|
2023-10-30 |
2026-07-07 |
알로젠 테라퓨틱스 인코포레이티드 |
조작된 세포
|
|
WO2025184529A1
(en)
|
2024-03-01 |
2025-09-04 |
Sana Biotechnology, Inc. |
Viral particles with fusogen display and related compositions and methods
|
|
WO2025217454A2
(en)
|
2024-04-11 |
2025-10-16 |
Capstan Therapeutics, Inc. |
Ionizable cationic lipids and lipid nanoparticles
|
|
WO2025217452A1
(en)
|
2024-04-11 |
2025-10-16 |
Capstan Therapeutics, Inc. |
Constrained ionizable cationic lipids and lipid nanoparticles
|
|
CN118108849B
(zh)
*
|
2024-04-28 |
2024-06-25 |
苏州睿瀛生物技术有限公司 |
一种抗cd33的纳米抗体制备方法和抗体的荧光标记流式应用
|